Skip to main content
logo
Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
9.79
+0.04 (0.41%)
Sep 14, 2026, 4:00 PM EDT - Market closed

Satellos Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
202899637726
Market Cap Growth
136.60%-6.65%160.46%440.53%-73.94%-
Enterprise Value
13954793421
Last Close Price
9.755.887.083.902.069.72

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.373.212.031.192.733.15
P/TBV Ratio
3.373.212.031.32-9.86

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.03-1.00-1.03-0.97-0.57-0.46
Net Debt / EBITDA Ratio
1.731.052.382.560.241.06
Net Debt / FCF Ratio
2.131.172.663.410.340.97
Quick Ratio
10.696.8413.6711.080.772.57
Current Ratio
11.227.7714.1611.130.792.59
Return on Equity (ROE)
-70.45%-66.37%-54.71%-72.15%-163.48%-301.13%
Return on Assets (ROA)
-41.89%-40.02%-31.27%-38.28%-56.08%-43.45%
Return on Capital Employed (ROCE)
-59.80%-95.20%-43.20%-38.00%-250.20%-45.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-17.14%-27.86%-21.57%-32.76%-123.13%-46.99%
FCF Yield
-14.37%-26.43%-19.09%-23.92%-61.40%-15.28%
Buyback Yield / Dilution
-46.32%-52.60%-32.84%-142.17%-48.20%-35.60%
SEC Filings: 10-K · 10-Q